跳至主要内容
临床试验/NL-OMON41631
NL-OMON41631已完成不适用

Treatment of the Medial Meniscus with the NUsurface® Meniscus Implant. A Prospective, Multi-Center, Open Label, Non-randomized Study of the NUsurface® Meniscus Implant - NUsurface Meniscus Implant

Active Implants Corporation0 个研究点目标入组 3 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • To be included in the NUsurface study the patient must have medial compartment knee pain and ALL of the following conditions:
  • 1.Have a degenerative and/or torn meniscus and/or previous meniscectomy as confirmed by diagnostic MRI.
  • 2.Have a pain score of 75 or less on the KOOS pain scale, with 100 being normal.
  • 3.Be in neutral alignment +/- 5 degrees of the mechanical axis.
  • 4.Be between age 35 and 75 at the time of the planned surgery.
  • 5.Be able to be fitted anatomically with a size 30 to 90 NUsurface® device.
  • 6.Have a normal mental status.
  • 7.Be willing and able to attend all follow up visits, complete all study questionnaires, and undergo required X-ray and MRI schedule.
  • 8.Be able and willing to understand and sign the informed consent form.

排除标准

  • The patient is excluded from the study if ANY of the following conditions are met for the involved knee:
  • 1.Have evidence of a Grade IV articular cartilage loss on the medial tibial plateau or femoral condyle that could contact the NUsurface implant
  • 2.Have lateral compartment pain with lateral articular cartilage damage greater than Grade II (OB), and/or a lateral meniscus tear(s)
  • 3.Have a varus or valgus knee deformity > 5 degrees.
  • 4.Have a laxity level of more than II (ICRS), secondary to previous injury of the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or lateral collateral ligament (LCL) and/or medial collateral ligament (MCL).
  • 5.Have patella instability or non-anatomically positioned patella
  • 6.Have patellar compartment pain and/or patellar articular cartilage damage greater than Grade II (OB).
  • 7.Need a tibial osteotomy at the time of surgery.
  • 8.Have an ACL reconstruction performed less than 9 months before implanting the NUsurface® device
  • 9.Have any type of previously implanted prosthetic meniscus or ligament or knee implant made of plastic.
  • 10.Have a knee flexion contracture > 10 degrees
  • 11.Be unable to flex the knee to 90 degrees
  • 12.Have a leg length discrepancy causing a noticeable limp.
  • 13.Have had a previous major knee condyle surgery
  • 14.Present with insufficiency fractures or avascular necrosis of the medial compartment.
  • 15.Have an active infection or tumor.
  • 16.Have any type of knee joint inflammatory disease including Sjogren*s syndrome.
  • 17.Have neuropathic knee osteoarthropathy, also known as Charcot joint.
  • 18.Have any medical condition that does not allow arthroscopy at the point of entry to the knee.
  • 19.Be pregnant or is a female intending to become pregnant during the study period.
  • 20.Be mentally incapacitated.
  • 21.Be a prisoner.
  • 22.Be a patient who has economic incentive not to improve (e.g., workman*s compensation patient)
  • 23.Be morbidly Obese (BMI > 35).
  • 24.Is unwilling or unable to have an X-ray, Fluro, or MRI of the affected knee

研究者

相似试验